Market Insider

Take a look at some of the biggest movers in the premarket: Moderna (MRNA) – The biotech company announced positive interim data from a phase 1 study of its novel coronavirus vaccine candidate. Moderna said dose-dependent increases in immune responses were seen across three different dose levels, and that the treatment was generally safe and
0 Comments
April retail sales are expected to have fallen by a record amount as Americans cut back spending on many nonessentials during the virus-related shutdowns. Economists expect April sales plunged by 12.3%, compared to the previous record drop of 8.7% in March, according to Dow Jones. Excluding automobiles, sales are expected to decline by 9.6% month-over-month,
0 Comments
An employee tends to marijuana plants at the Aurora Cannabis Inc. facility in Edmonton, Alberta, Canada, on Tuesday, March 6, 2018. Jason Franson | Bloomberg | Getty Images Check out the companies making headlines after the bell. Applied Materials — Shares of the manufacturing company climbed 4% in extended trading after Applied Materials reported second-quarter
0 Comments
Take a look at some of the biggest movers in the premarket: CyberArk Software (CYBR) – The cybersecurity company reported quarterly profit of 50 cents per share, beating the consensus estimate of 36 cents a share. Revenue also beat forecasts. CyberArk said that due to the pandemic, it expected customers to make “more cautious” purchasing
0 Comments
Chad Robins, CEO of Adaptive Biotechnologies. Anjali Sundaram | CNBC Check out the companies making headlines after the bell. Adaptive Biotechnologies – The biotechnology company’s stock fell 5% in extended trading after Adaptive gave its first-quarter financial results. The company reported a loss of 25 cents per share on revenue of $20.9 million, while analysts
0 Comments
A worker examines cannabis plants at a Tilray farm. Source: Tilray Check out the companies making headlines after the bell. Novavax — The vaccine company’s stock skyrocketed 37% in extended trading after Novavax highlighted an outside investment of $388 million to advance the clinical development of its coronavirus vaccine candidate in its first-quarter earnings release. The
0 Comments
Take a look at some of the biggest movers in the premarket: Raytheon Technologies (RTX) – The defense contractor reported quarterly profit of $1.78 per share, beating the consensus estimate of $1.22 a share. Revenue also beat forecasts and Raytheon said it would not provide a financial outlook at this time due to pandemic-related uncertainty.
0 Comments